Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Johns Hopkins researchers synthesize antimalarial drug candidates

Jan. 21, 1998

Potential target for a malaria vaccine identified

Jan. 21, 1998

PDMP analogues studied for malaria inhibition

Jan. 21, 1998

Antiviral agents that inhibit virus-host cell fusion pursued by Lilly

Jan. 21, 1998

Novel antifungal peptides isolated by Hoechst Marion Roussel

Jan. 21, 1998

Lilly discloses new agents for influenza

Jan. 20, 1998

Novel semisynthetic macrolides prepared at Abbott

Jan. 20, 1998

Lilly discloses novel compounds for influenza

Jan. 19, 1998

Merck & Co. claims carbapenems active against methicillin-resistant staphylococci

Jan. 19, 1998

Preclinical evaluation of leishmaniasis Rx reported

Jan. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....